Sort   by:  
 Page size 
UnknownDeletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.
Not available
S-EPMC6642117 | biostudies-literature
UnknownMeningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
Not available
S-EPMC9374001 | biostudies-literature
UnknownCommunity-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
Not available
S-EPMC11761538 | biostudies-literature
UnknownPrehospital use of magnesium sulfate as neuroprotection in acute stroke.
Not available
S-EPMC4920545 | biostudies-literature
UnknownOpportunities and challenges for monitoring terrestrial biodiversity in the robotics age.
Not available
S-EPMC12148927 | biostudies-literature
UnknownBREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.
Not available
S-EPMC7617909 | biostudies-literature
UnknownEfficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
Not available
S-EPMC4643643 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Not available
S-EPMC3235490 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
Sort   by:  
 Page size